Cadila Healthcare Limited Stock Bombay S.E.
Equities
CADI
INE010B01019
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- INR | - |
Sales 2024 | 195B 2.35B | Sales 2025 * | 217B 2.61B | Capitalization | 1,060B 12.74B |
---|---|---|---|---|---|
Net income 2024 | 38.6B 464M | Net income 2025 * | 42.66B 513M | EV / Sales 2024 | 5.19 x |
Net cash position 2024 * | 13.47B 162M | Net cash position 2025 * | 29.52B 355M | EV / Sales 2025 * | 4.74 x |
P/E ratio 2024 |
26.4
x | P/E ratio 2025 * |
25.3
x | Employees | - |
Yield 2024 * |
0.55% | Yield 2025 * |
0.51% | Free-Float | 24.87% |
Latest transcript on Cadila Healthcare Limited
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | 97-07-31 | |
Director of Finance/CFO | - | - | |
Chairman | 71 | 95-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 18-12-05 | |
Chairman | 71 | 95-05-14 | |
Director/Board Member | 69 | 97-07-31 |
1st Jan change | Capi. | |
---|---|---|
+16.31% | 42.32B | |
+16.32% | 21.29B | |
+19.33% | 15.29B | |
+18.71% | 14.36B | |
-0.05% | 6.79B | |
-12.24% | 6.58B | |
-8.87% | 5.73B | |
+11.64% | 5.51B | |
+7.31% | 4.91B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- CADI Stock